Loading... Please wait... Loading... Please wait...
ESTIMATED
04/25/2024
04/25/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 4 | $1.89 | $1.89 | $1.89 |
| Q2 2024 | 12 | $2.04 | $2.26 | $2.15 |
| Q3 2024 | 5 | $2.32 | $2.32 | $2.32 |
| Q4 2024 | 5 | $2.11 | $2.11 | $2.11 |
| Q1 2025 | 6 | $2.33 | $2.33 | $2.33 |
| Q2 2025 | 6 | $2.43 | $2.43 | $2.43 |
| Q3 2025 | 6 | $2.59 | $2.59 | $2.59 |
| Q4 2025 | 6 | $2.32 | $2.32 | $2.32 |
Merck & Co., Inc. last posted its earnings results on Thursday, April 25th, 2024. The company reported $1.91 earnings per share for the quarter, topping analysts' consensus estimates of $1.73 by $0.18. The company had revenue of 15.81 B for the quarter and had revenue of 59.87 B for the year. Merck & Co., Inc. has generated $0 earnings per share over the last year ($0.14 diluted earnings per share) and currently has a price-to-earnings ratio of 140.49. Merck & Co., Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 30th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/03/2024 | Q1 2024 | $1.88 | $15.21 B | $15.81 B | 04/11/2024 | Q4 2023 | -$0.48 | $14.49 B | $14.63 B | 11/03/2023 | Q3 2023 | $1.87 | $15.96 B | 08/07/2023 | Q2 2023 | -$2.35 | $15.04 B | 05/05/2023 | Q1 2023 | $1.11 | $13.79 B | $14.49 B | 02/24/2023 | Q4 2022 | $1.19 | $13.66 B | $13.83 B | 11/03/2022 | Q3 2022 | $1.28 | $14.96 B | 08/04/2022 | Q2 2022 | $1.56 | $14.59 B | 05/05/2022 | Q1 2022 | $1.70 | $14.56 B | $15.90 B | 02/25/2022 | Q4 2021 | $1.49 | $13.16 B | $13.52 B | 11/05/2021 | Q3 2021 | $1.81 | $12.32 B | $13.15 B | 08/09/2021 | Q2 2021 | $0.61 | $11.23 B | $11.40 B | 05/05/2021 | Q1 2021 | $1.26 | $12.61 B | $12.08 B | 02/25/2021 | Q4 2020 | -$0.83 | $12.67 B | $12.51 B | 11/05/2020 | Q3 2020 | $1.16 | $12.21 B | $12.55 B | 08/05/2020 | Q2 2020 | $1.19 | $10.40 B | $10.87 B | 05/06/2020 | Q1 2020 | $1.28 | $11.48 B | $12.06 B | 02/26/2020 | Q4 2019 | $0.93 | $11.98 B | $11.87 B | 11/05/2019 | Q3 2019 | $0.75 | $11.64 B | $12.40 B | 08/06/2019 | Q2 2019 | $1.04 | $10.96 B | $11.76 B |
|---|
A. Merck & Co., Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, July 30th, 2024 based off last year's report dates.
A. In the previous quarter, Merck & Co., Inc. (NYSE:MRK) reported $1.91 earnings per share (EPS) to beat the analysts' consensus estimate of $1.73 by $0.18.
A. The conference call for Merck & Co., Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Merck & Co., Inc.'s latest earnings report can be read online.
A. Merck & Co., Inc. (NYSE:MRK) has a recorded annual revenue of $59.87 B.
A. Merck & Co., Inc. (NYSE:MRK) has a recorded net income of $59.87 B. Merck & Co., Inc. has generated $0.14 earnings per share over the last four quarters.
A. Merck & Co., Inc. (NYSE:MRK) has a price-to-earnings ratio of 140.49 and price/earnings-to-growth ratio is 21.08.
